DK0839041T3 - Salte af amidinderivater og cyclooxygenaseinhibitorer, deres fremstillingsmåde og anvendelse som medikamenter og farmaceutiske sammensætninger indeholdende disse - Google Patents

Salte af amidinderivater og cyclooxygenaseinhibitorer, deres fremstillingsmåde og anvendelse som medikamenter og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0839041T3
DK0839041T3 DK96925786T DK96925786T DK0839041T3 DK 0839041 T3 DK0839041 T3 DK 0839041T3 DK 96925786 T DK96925786 T DK 96925786T DK 96925786 T DK96925786 T DK 96925786T DK 0839041 T3 DK0839041 T3 DK 0839041T3
Authority
DK
Denmark
Prior art keywords
salts
pharmaceutical compositions
compositions containing
pct
medicaments
Prior art date
Application number
DK96925786T
Other languages
Danish (da)
English (en)
Inventor
De Lassauniere Pierre Chabrier
Colette Broquet
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK0839041T3 publication Critical patent/DK0839041T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96925786T 1995-07-15 1996-07-15 Salte af amidinderivater og cyclooxygenaseinhibitorer, deres fremstillingsmåde og anvendelse som medikamenter og farmaceutiske sammensætninger indeholdende disse DK0839041T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514518.1A GB9514518D0 (en) 1995-07-15 1995-07-15 Guanidine salt inhibitors of NO synthase and cyclooxygenase
PCT/FR1996/001095 WO1997003678A1 (fr) 1995-07-15 1996-07-15 Sels de derives d'amidine et d'inhibiteur de cyclooxygenase, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
DK0839041T3 true DK0839041T3 (da) 2004-08-09

Family

ID=10777740

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96925786T DK0839041T3 (da) 1995-07-15 1996-07-15 Salte af amidinderivater og cyclooxygenaseinhibitorer, deres fremstillingsmåde og anvendelse som medikamenter og farmaceutiske sammensætninger indeholdende disse

Country Status (24)

Country Link
US (1) US6063807A (xx)
EP (1) EP0839041B1 (xx)
JP (1) JPH11509540A (xx)
CN (1) CN1187056C (xx)
AT (1) ATE264107T1 (xx)
AU (1) AU704373B2 (xx)
CA (1) CA2227034A1 (xx)
CZ (1) CZ293676B6 (xx)
DE (1) DE69632193T2 (xx)
DK (1) DK0839041T3 (xx)
ES (1) ES2219690T3 (xx)
GB (1) GB9514518D0 (xx)
HU (1) HUP9901331A3 (xx)
IL (1) IL122737A (xx)
MX (1) MX9800408A (xx)
NO (1) NO980178D0 (xx)
NZ (1) NZ313654A (xx)
PL (1) PL185375B1 (xx)
PT (1) PT839041E (xx)
RU (1) RU2167856C2 (xx)
TW (1) TW474908B (xx)
UA (1) UA53624C2 (xx)
WO (1) WO1997003678A1 (xx)
ZA (1) ZA965969B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US7255854B1 (en) 1996-10-25 2007-08-14 Biogen, Inc. Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases
AU784490B2 (en) * 1999-12-08 2006-04-13 Pharmacia Corporation Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
EP1303265B1 (en) 2000-07-20 2007-07-11 Lauras AS Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
MY137736A (en) 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
EP1494664A2 (en) * 2002-04-18 2005-01-12 Pharmacia Corporation Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
MXPA04010186A (es) * 2002-04-18 2005-02-03 Pharmacia Corp Monoterapia para el tratamiento de la enfermedad de parkinson con inhibidor (es) de la ciclooxigenasa-2 (cox 2).
EP2073833A2 (en) 2006-10-20 2009-07-01 Biogen Idec MA Inc. Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
US20090155430A1 (en) * 2007-12-14 2009-06-18 E.I. Du Pont De Nemours And Company Films comprising liquid smoke and flavorants
RU2478618C2 (ru) * 2010-03-15 2013-04-10 Закрытое Акционерное Общество "Инфарма" Новое биологически активное соединение n-[3-(4-нитрофениламино)-индол-2-илметилен] аминогуанидина гидрохлорид с противовоспалительной активностью
RU2480452C1 (ru) * 2012-01-11 2013-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПХФА Минздрава России) Способ получения n-4-нитрофенилбензамидина
RU2684117C1 (ru) * 2018-10-29 2019-04-04 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Способ получения N-(нафталин-2-ил)бензамидина
CN109678715B (zh) * 2018-11-28 2019-11-12 中国药科大学 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途
RU2694263C1 (ru) * 2019-02-14 2019-07-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Анальгезирующее и противовоспалительное средство с противомикробной активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56147761A (en) * 1980-04-15 1981-11-16 Banyu Pharmaceut Co Ltd Salt compound consisting of acetylsalicylic acid and diguanidine, its preparation and agent containing the same as active constitutent
US4324801A (en) * 1981-04-21 1982-04-13 Banyu Pharmaceutical Co. Ltd. Phenylguanidine acetylsalicylate compounds, process for production thereof, and pharmaceutical composition thereof
JPS61143320A (ja) * 1985-11-08 1986-07-01 Banyu Pharmaceut Co Ltd 微小循環器系改善剤
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
JPH11509540A (ja) 1999-08-24
AU704373B2 (en) 1999-04-22
MX9800408A (es) 1998-04-30
ES2219690T3 (es) 2004-12-01
DE69632193T2 (de) 2005-05-04
HUP9901331A2 (hu) 1999-08-30
NO980178L (no) 1998-01-14
NO980178D0 (no) 1998-01-14
IL122737A (en) 2003-01-12
EP0839041B1 (fr) 2004-04-14
UA53624C2 (uk) 2003-02-17
CA2227034A1 (fr) 1997-02-06
CZ293676B6 (cs) 2004-06-16
ZA965969B (en) 1997-10-31
PL324490A1 (en) 1998-05-25
TW474908B (en) 2002-02-01
HUP9901331A3 (en) 1999-11-29
PT839041E (pt) 2004-09-30
CZ7398A3 (cs) 1998-06-17
WO1997003678A1 (fr) 1997-02-06
AU6617596A (en) 1997-02-18
EP0839041A1 (fr) 1998-05-06
GB9514518D0 (en) 1995-09-13
ATE264107T1 (de) 2004-04-15
NZ313654A (en) 1999-10-28
RU2167856C2 (ru) 2001-05-27
CN1187056C (zh) 2005-02-02
CN1190890A (zh) 1998-08-19
US6063807A (en) 2000-05-16
PL185375B1 (pl) 2003-04-30
IL122737A0 (en) 1998-08-16
DE69632193D1 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
DK0839041T3 (da) Salte af amidinderivater og cyclooxygenaseinhibitorer, deres fremstillingsmåde og anvendelse som medikamenter og farmaceutiske sammensætninger indeholdende disse
DK1475377T3 (da) Indol-derivater og deres anvendelse som inhibitorer for phosphodiesterase 4
NO20002787L (no) Nye forbindelser
NO972881D0 (no) Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling
BR9916111A (pt) Derivados de fenilglicina
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
BR0010220A (pt) Compostos de pirimidinona
FI962800A (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
NO20020687L (no) 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
DK1223933T3 (da) 5-leddet derivater af heterocyklusser og deres anvendelse som monoaminoxidaseinhibitorer
NO20001102L (no) 2,3-diaryl-pyrazolo[1,5-B]pyridazinderivater, deres fremstilling og anvendelse som cyklo-oksygenase 2 (COX-2) inhibitorer
DK1304327T3 (da) Glutamin-thiazolidider og -pyrrolidider samt anvendelsen af disse som dipeptidylpeptidase-IV-inhibitorer
NO996491L (no) 4-brom- eller 4-iod-fenylaminobenzhydroksamsyre-derivater og deres anvendelse som MEK-inhibitorer
DK1006110T3 (da) Derivater af acylpiperazinylpyrimidiner, fremstilling deraf og anvendelse som lægemidler
NO984290L (no) Farmas°ytisk nyttige forbindelser
DK0973763T3 (da) Hidtil ukendte 2-(iminomethyl)aminophenylderivater, fremstilling af disse, anvendelse af disse i egenskab af lægemidler og farmaceutiske præparater indeholdende disse
BR0109542A (pt) Derivados de imidazopirina alquilados
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
DK0839149T3 (da) Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
DK0782575T3 (da) Substituerede pyrazol-pyrazol-derivater, fremgangsmåde til deres fremsstilling samt deres anvendelse som midler med herbicid virkning
NO20001149L (no) Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasøytiske midler
TR200100133T2 (tr) FKBP İnhibitörleri
DK1017681T3 (da) Hydrazon-benzazulenderivater, farmaceutiske præparater og mellemprodukter
NO20000094L (no) 6-Azaurcilderivater som IL-5 inhibitorer